# Edwards Lifesciences to build €80M heart valve plant in Ireland

Edwards Lifesciences Corporation chose the Mid-West of Ireland for a new plant to manufacture delivery components for transcatheter heart valve therapies. Investment is expected to be €80 million, with 600 jobs when fully operational. Initial site in Shannon Free Zone, new facility planned for completion in 2020.

- Type: New facility
- Announced: 2018-03-05
- Where: Mid-West of Ireland, Shannon Free Zone, Ireland
- Value: $99.0M (80.0M EUR)
- Jobs: 600
- Starts operating: 2020
- Status: announced
- Products: delivery components for transcatheter heart valve therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md)

## Sources

- [enterprise.gov.ie](https://enterprise.gov.ie/en/news-and-events/department-news/2018/march/05032018.html), 2018-03-05: "The addition of a manufacturing location in Ireland is an element of Ed"
- [clare.fm](https://www.clare.fm/news/600-jobs-created-following-80-million-euro-investment-mid-west-3/), 2018-03-05: "The Mid West has beaten off stiff competition to secure an 80 million euro investment from Edward Lifesciences."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.